Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.57 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.50 |
| ▸ | HTR3B | O95264 | 2/20 | 0.50 |
| ▸ | HTR3A | P46098 | 2/20 | 0.50 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.50 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | VCP | P55072 | 1/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.48 |
| ▸ | CKS1B | P61024 | 1/20 | 0.47 |
| ▸ | SKP1 | P63208 | 1/20 | 0.47 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17927700 | 0.98 | MBTD1 (0.55) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL17748967 | 0.98 | MBTD1 (0.55) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| SCHEMBL14275856 | 0.92 | L3MBTL1 (0.55) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| SCHEMBL7845352 | 0.87 | MBTD1 (0.46) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| SCHEMBL314421 | 0.87 | NOTUM (0.55) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| SCHEMBL8386956 | 0.87 | NOTUM (0.55) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| SCHEMBL21628259 | 0.87 | NOTUM (0.55) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL30775623 | 0.85 | NOTUM (0.53) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL30775632 | 0.85 | NOTUM (0.53) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B | |
| SCHEMBL4477880 | 0.84 | MBTD1 (0.59) | MBTD1L3MBTL3L3MBTL1HTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116768862-A | Indole pyrazole compound as well as preparation method and application thereof | 郑州大学 | 2023-09-19 | — | — | CN | claimed |
| CN-1262548-C | Synthesis of benzoxazine monohydrochlorate compound | XINYI WANXIANG PHARMACEUTICAL (CN) | 2006-07-05 | — | — | CN | claimed |
| CN-1552699-A | Synthesis of benzoxazine monohydrochlorate compound | 上海延安万象药业股份有限公司 | 2004-12-08 | — | — | CN | claimed |
| EP-0481288-B1 | 1-Phenylpiperid-4-ylamines and drugs containing them | BASF AG (DE) | 1995-07-26 | — | — | EP | claimed |
| WO-2026107349-A1 | HETEROCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASES | ANTARES THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12630531-B2 | Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient | OMIC SMAP INC. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12606541-B2 | PPARg modulators and methods of use | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20260070884-A1 | Inhibitors of Dihydroceramide Desaturase for Treating Disease | CENTAURUS THERAPEUTICS (US) | 2026-03-12 | — | — | US | disclosed |
| CN-120117949-A | Method for directly preparing tertiary amine compound from aromatic aldehyde, ketone and secondary amine | 湖南大学 | 2025-06-10 | — | — | CN | disclosed |
| US-12247019-B2 | Inhibitors of dihydroceramide desaturase for treating disease | CENTAURUS THERAPEUTICS (US) | 2025-03-11 | — | — | US | disclosed |
| US-20240246964-A1 | SUBSTITUTED 1-ARYL-1’-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1’-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME | ARBUTUS BIOPHARMA CORPORATION (CA) | 2024-07-25 | — | — | US | disclosed |
| EP-4370512-A1 | CD38 MODULATORS AND METHODS OF USE THEREOF | Cytokinetics, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| WO-1998008842-A1 | CYCLIC ETHER COMPOUNDS AS SODIUM CHANNEL MODULATORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-05 | — | — | WO | disclosed |
| WO-1997038665-A2 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| EP-0481288-B1 | 1-Phenylpiperid-4-ylamines and drugs containing them | BASF AG (DE) | 1995-07-26 | — | — | EP | disclosed |
| EP-0481288-B1 | 1-Phenylpiperid-4-ylamines and drugs containing them | BASF AG (DE) | 1995-07-26 | — | — | EP | disclosed |
| US-5317015-A | Azacyclic bisphosphonates as anticholesterolemic agents | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-05-31 | — | — | US | disclosed |
| CN-1080918-A | Novel aminopropanol derivatives, pharmaceutical compositions containing them and process for preparing them | RICHTER GEDEON VEGYESZET (HU) | 1994-01-19 | — | — | CN | disclosed |
| WO-1993025528-A1 | NOVEL AMINOPROPANOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 1993-12-23 | — | — | WO | disclosed |
| EP-0481288-A2 | 1-Phenylpiperid-4-ylamines and drugs containing them | BASF Aktiengesellschaft (DE) | 1992-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070884-A1 | Inhibitors of Dihydroceramide Desaturase for Treating Disease | CERS2, DEGS1, CERT1 | MBTD1 4556/4885L3MBTL3 3290/4885L3MBTL1 1806/4885 |
| US-12247019-B2 | Inhibitors of dihydroceramide desaturase for treating disease | CERS2, SMPD1, ASAH1 | MBTD1 2753/4885L3MBTL3 3644/4885L3MBTL1 1542/4885 |
| US-20240246964-A1 | SUBSTITUTED 1-ARYL-1’-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1’-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME | HAVCR2, HDGF, HCCS | MBTD1 1966/4885L3MBTL3 684/4885L3MBTL1 869/4885 |
| US-12630531-B2 | Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient | EHMT2, EHMT1, HNMT | MBTD1 538/4885L3MBTL3 1415/4885L3MBTL1 951/4885 |
| US-12606541-B2 | PPARg modulators and methods of use | PPARG, PPARA, PPARD | MBTD1 4378/4885L3MBTL3 4712/4885L3MBTL1 4535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.